Zhejiang Haisen Pharmaceutical Co., Ltd. FDA Record
Zhejiang Haisen Pharmaceutical Co., Ltd. has 0 FDA recalls, 4 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Zhejiang Haisen Pharmaceutical Co., Ltd." is on file.
- Latest inspection
- Nov 15, 2024 · VAI
Summary
| Records | Count | Last refreshed | Source as of | Status |
|---|---|---|---|---|
| Recalls | 0 | Nov 8, 2026 | File dated Nov 3, 2026 | Current |
| 510(k) clearances | 0 | Nov 8, 2026 | File dated Nov 2, 2026 | Current |
| Inspections | 4 | Nov 14, 2026 | Newest record Nov 5, 2026 | Current |
| Compliance actions | 0 | Nov 2, 2026 | Newest record Oct 29, 2026 | Current |
FDA record by year
| Year | Inspections | OAI | Warning letters | Recall records | Class I |
|---|---|---|---|---|---|
| 2026 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 1 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 |
| 2022 | 0 | 0 | 0 | 0 | 0 |
| 2021 | 0 | 0 | 0 | 0 | 0 |
| 2020 | 0 | 0 | 0 | 0 | 0 |
| 2019 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 1 | 1 | 0 | 0 | 0 |
| 2017 | 1 | 1 | 0 | 0 | 0 |
Reviewing Zhejiang Haisen Pharmaceutical Co., Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or check Zhejiang Haisen Pharmaceutical Co., Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.
Recent FDA inspections
| Date | Site | Product | Classification | FEI |
|---|---|---|---|---|
| Nov 15, 2024 | Dongyang, China | Drugs | Voluntary Action Indicated (VAI) | 3003967524 |
| Apr 11, 2018 | Dongyang, China | Veterinary | Official Action Indicated (OAI) | 3003967524 |
| Apr 21, 2017 | Dongyang, China | Veterinary | Official Action Indicated (OAI) | 3003967524 |
| Dec 12, 2014 | Dongyang, China | Drugs | No Action Indicated (NAI) | 3003967524 |
- NAI
- No objectionable conditions or practices were found during the inspection.
- VAI
- Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
- OAI
- Regulatory and/or administrative actions are recommended.
FDA-inspected facilities
| Facility | Location | Inspections | Latest |
|---|---|---|---|
| FEI 3003967524 | Dongyang, China | 4 | Nov 15, 2024 |
Zhejiang Haisen Pharmaceutical Co., Ltd. and the FDA: common questions
Has Zhejiang Haisen Pharmaceutical Co., Ltd. received an FDA warning letter?
No FDA warning letter addressed to the name "Zhejiang Haisen Pharmaceutical Co., Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.
Has Zhejiang Haisen Pharmaceutical Co., Ltd. received an FDA Form 483?
FDA has not published a Form 483 for "Zhejiang Haisen Pharmaceutical Co., Ltd." in its reading room. FDA publishes some Form 483s, not all of them.
When did the FDA last inspect Zhejiang Haisen Pharmaceutical Co., Ltd.?
The most recent FDA inspection on file ended Nov 15, 2024 at Dongyang, China and was classified VAI. FDA has 4 inspections of Zhejiang Haisen Pharmaceutical Co., Ltd. on file, 2 of them classified OAI (official action indicated).
Need more than this page shows? Ask about Zhejiang Haisen Pharmaceutical Co., Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.